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ABSTRACT 
Although synaptotagmin I, which is a calcium (Ca
2+
)-binding synaptic vesicle protein, may 
trigger soluble N-ethylmaleimide-sensitive factor attachment protein receptor 
(SNARE)-mediated synaptic vesicle exocytosis, the mechanisms underlying the interaction 
between these proteins remains controversial, especially with respect to the identity of the 
protein(s) in the SNARE complex that bind(s) to synaptotagmin and whether Ca
2+
 is required 
for their highly effective binding. To address these questions, native proteins were solubilized, 
immunoprecipitated from rat brain extracts, and analyzed by immunoblotting. SNARE 
complexes comprising syntaxin 1, 25-kDa synaptosomal-associated protein (SNAP-25), and 
synaptobrevin 2 were coprecipitated with synaptotagmin I in the presence of ethylene glycol 
tetraacetic acid. The amount of coprecipitated proteins was significantly unaltered by the 
addition of Ca
2+
 to the brain extract. To identify the component of the SNARE complex that 
bound to synaptotagmin, SNARE was coexpressed with synaptotagmin in HEK293 cells and 
immunoprecipitated. Syntaxin, but not SNAP-25 and synaptobrevin, bound to synaptotagmin 
in a Ca
2+
-independent manner, and the binding was abolished in the presence of 1 M NaCl. 
Synaptotagmin contains 2 Ca
2+
-binding domains (C2A, C2B). Mutating the positively charged 
lysine residues in the putative effector-binding region of the C2B domain, which are critical 
for transmitter release, markedly inhibited synaptotagmin-syntaxin binding, while similar 
mutations in the C2A domain had no effect on binding. Synaptotagmin-syntaxin binding was 
reduced by mutating multiple negatively charged glutamate residues in the amino-terminal 
half of the syntaxin SNARE motif. These results indicate that synaptotagmin I binds to 
syntaxin 1 electrostatically through its C2B domain effector region in a Ca
2+
-independent 
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fashion, providing biochemical evidence that synaptotagmin I binds SNARE complexes 
before Ca
2+
 influx into presynaptic nerve terminals. 
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Introduction 
Signal transmission between neurons is mediated by neurotransmitters stored in synaptic 
vesicles at presynaptic nerve terminals. When an action potential arrives at the nerve terminal, 
calcium ion (Ca
2+
) influx through voltage-gated Ca
2+
 channels triggers synaptic vesicle 
exocytosis. Vesicle exocytosis is caused by soluble N-ethylmaleimide-sensitive factor attachment 
protein receptors (SNAREs) (Jahn and Scheller, 2006; Rothman, 1994; Südhof, 2008). SNAREs 
are classified as follows: v-SNAREs (synaptobrevin 2), which are localized in the vesicular 
membrane, and t-SNAREs (syntaxin 1 and SNAP-25), which are localized on the target plasma 
membrane. These SNAREs possess a SNARE motif with a coiled-coil structure in the 
cytoplasmic regions. Each SNARE motif in synaptobrevin and syntaxin and the 2 motifs in 
SNAP-25 form a SNARE complex with 4 parallel helix bundles (Sutton et al., 1998), which may 
bring vesicular and target membranes into close proximity, leading to membrane fusion. 
In in vitro experiments, v-SNARE- and t-SNARE-reconstituted liposomes fuse with each 
other (Weber et al., 1998). While SNAREs are constitutively active and show no sensitivities for 
Ca
2+
 in promoting liposome fusion, synaptic vesicle exocytosis in presynaptic nerve terminals is 
strictly regulated by Ca
2+
. Thus, Ca
2+
 binds another protein that serves as a Ca
2+
 sensor, thereby 
promoting SNARE-mediated vesicle exocytosis. The best candidate for such a Ca
2+
 sensor for 
neurotransmitter release is the synaptic vesicle membrane protein synaptotagmin I (Augustine, 
2001; Chapman, 2008; Südhof, 2008). Synaptotagmin has 2 homologous Ca
2+
-binding domains 
(C2A, C2B) that are connected by a short linker in the cytoplasmic region. Genetic knockout 
studies have demonstrated that synaptotagmin I regulates Ca
2+
-dependent neurotransmitter 
release in 2 different ways: by triggering synchronous release and by suppressing asynchronous 
release (Nishiki and Augustine, 2004b; Shin et al., 2003; Yoshihara and Littleton, 2002). Ca
2+
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binding to the C2B domain is more important than its binding to the C2A domain for 
synaptotagmin to synchronize transmitter release in response to an action potential (Mackler et al., 
2002; Nishiki and Augustine, 2004a; Robinson et al., 2002). Many studies have shown that Ca
2+
 
promotes synaptotagmin binding to individual t-SNAREs as well as to t-SNARE heterodimers 
and trimeric SNARE complexes (Bai et al., 2004b; Dai et al., 2007; Fernández-Chacón et al., 
2001; Zhang et al., 2002), and these results provide an attractive model in which Ca
2+
 influx can 
be directly coupled to membrane fusion.  
In contrast to the triggering of synchronous release, synaptotagmin suppresses asynchronous 
release in a Ca
2+
-independent manner (Kochubey and Schneggenburger, 2011; Nishiki and 
Augustine, 2004a). Synaptotagmin inhibits SNARE-mediated liposome fusion in the absence of 
Ca
2+
 in vitro (Chicka et al., 2008). These findings raise the possibility that synaptotagmin 
regulates SNARE function at resting Ca
2+
 levels in nerve terminals. Although some studies have 
demonstrated significant synaptotagmin-SNARE binding in the absence of Ca
2+
 (Rickman and 
Davletov, 2003; Weninger et al., 2008), many biochemical studies have shown little binding 
without Ca
2+
 (Bai et al., 2004b; Dai et al., 2007; Fernández-Chacón et al., 2001; Wang et al., 
2003). Moreover, a study reported that neither Ca
2+
-dependent nor -independent interactions 
occur at physiological ionic strengths (Tang et al., 2006). While many researchers have used 
bacterial-expressed and truncated recombinant fusion proteins with various affinity tags in 
binding studies, the results obtained with such recombinants are inconsistent and contradictory. 
Thus, despite the substantial research that has been conducted for the past 20 years, there is no 
general agreement of the exact properties of synaptotagmin-SNARE binding. 
To better understand the synaptotagmin I-SNARE interaction, we herein examined their 
binding using solubilized natural proteins from the brain and full-length recombinant proteins 
 6 
without any affinity tags that were expressed in mammalian cells. We found that synaptotagmin I 
and SNAREs bound each other in the absence of Ca
2+
 at physiological ionic strengths and that 
the Ca
2+
-independent synaptotagmin I-SNARE complex binding was possibly mediated through 
a synaptotagmin I-syntaxin 1 interaction. Moreover, we demonstrated that synaptotagmin bound 
to syntaxin through electrostatic interactions between positive charges in the synaptotagmin C2B 
domain and the partly negative charges in the N-terminal half of the syntaxin SNARE motif. 
These results provide biochemical and experimental evidence for synaptotagmin I-SNARE 
complex binding before Ca
2+
 influx into presynaptic nerve terminals. 
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Results 
 
Ca
2+
-independent synaptotagmin-SNARE complex binding in brain extracts 
 
In order to examine the properties of synaptotagmin-SNARE complex binding, natural 
proteins from rat brain synaptosomes were solubilized with detergent, immunoprecipitated, and 
then analyzed by immunoblotting. When synaptotagmin was immunoprecipitated with an 
anti-synaptotagmin I antibody, all SNAREs were found to specifically coprecipitate in the 
presence of 0.15 M NaCl and 2 mM ethylene glycol tetraacetic acid (EGTA; Fig. 1A, 1
st
 versus 
3
rd
 lanes). Under these conditions, 4.40 ± 0.23% of synaptotagmin was precipitated from the total 
brain extract by the antibody, while 0.68 ± 0.08% of syntaxin, 2.00 ± 0.14% of SNAP-25, and 
0.75 ± 0.08% of synaptobrevin 2 were coprecipitated (mean ± SEM, n = 3). The specific 
coprecipitation of synaptotagmin and SNARE complexes was completely disrupted by adding 
NaCl to the brain extract at a final concentration of 1 M (Fig. 1A, 1
st
 versus 4
th
 lanes), which is 
consistent with the results reported by Rickman and Davletov (2003). When an 
anti-synaptobrevin 2 antibody was used for immunoprecipitation, a similar result was obtained 
with the efficiencies of precipitation as follows: 0.89 ± 0.16% for synaptotagmin, 2.70 ± 0.25% 
for syntaxin, 1.80 ± 0.15% for SNAP-25, and 9.01 ± 0.33% of synaptobrevin (Fig. 1A, 2
nd
 and 5
th
 
lanes). 
In order to test whether Ca
2+
 enhances synaptotagmin-SNARE binding, 1 mM CaCl2 was 
added to the brain extracts, and immunoprecipitation was performed. Surprisingly, the addition of 
Ca
2+
 had no significant effects on the amount of SNAREs that coprecipitated with 
synaptotagmin: syntaxin was decreased by 11.7 ± 1.0%; SNAP-25 was decreased by 9.4 ± 2.9%; 
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and synaptobrevin 2 was increased by 6.4 ± 3.5% (mean ± SEM, n = 3; Fig. 1B, 1
st
 versus 2
nd
 
lanes). Similar results were found for the amount of synaptotagmin that coprecipitated with the 
anti-synaptobrevin antibody (26.8 ± 8.0% increase; Fig. 1B, 3
rd
 versus 4
th
 lanes). Based on these 
results, we concluded that natural synaptotagmin and SNARE proteins from the brain that were 
solubilized bound to each other through electrostatic interactions in a Ca
2+
-independent manner at 
physiological ionic strengths. 
 
Ca
2+
-independent recombinant synaptotagmin-SNARE binding 
 
In order to determine which protein in the SNARE complex binds to synaptotagmin in the 
absence of Ca
2+
, syntaxin 1, SNAP-25, or synaptobrevin 2 was coexpressed with synaptotagmin I 
in HEK293 cells by the transfection of plasmids that encoded full-length proteins without any 
tags. The expression levels of the recombinant proteins in the cotransfected cells were examined 
by immunoblotting. All 4 proteins were expressed at the expected molecular weights, and 
cotransfection of each SNARE had no effect on synaptotagmin expression levels (Fig. 2A). After 
solubilizing the transfected cells, synaptotagmin was immunoprecipitated from the cell lysate. 
Immunoblotting analysis of the precipitates revealed that syntaxin, and not SNAP-25 and 
synaptobrevin, specifically coprecipitated with synaptotagmin (Fig. 2B). When SNAP-25 was 
coexpressed with synaptotagmin, a faint band that migrated to a position similar to that of 
SNAP-25 was detected. This band was believed to be nonspecific because it was also found in 
immunoprecipitates from the cell lysates that did not coexpress SNAP-25 with a control antibody. 
Ca
2+
-independent synaptotagmin-syntaxin binding was disturbed almost completely (97%) in the 
presence of 1 M NaCl in the cell lysate (Fig. 2C), indicating that the binding was an electrostatic 
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interaction that was mediated by the cytoplasmic regions and not by nonspecific hydrophobic 
interactions between the transmembrane regions in detergent micelles. Thus, these results suggest 
that synaptotagmin I binds electrostatically to SNARE complexes through an interaction with 
syntaxin 1, and not with SNAP-25 or synaptobrevin 2, in the absence of Ca
2+
. 
 
Syntaxin-binding sites on synaptotagmin 
 
In order to determine the region of synaptotagmin that is involved in Ca
2+
-independent 
binding to syntaxin, we performed point mutagenesis. Each synaptotagmin C2 domain has a 
curved -sandwich structure that is composed of 2 4-stranded  sheets with loops, and the surface 
of the concave  sheet was assumed to be an effector-binding region of this protein (Fig. 3A) 
(Fernandez et al., 2001; Sutton et al., 1995). At the edge of the concave sheet, multiple highly 
conserved basic amino acid residues are adjacently located in the fourth  (4) strand (C2A, 
189–200; C2B, 321–332). We then examined the involvement of these basic residues of 
synaptotagmin C2 domains in the binding to syntaxin. 
All 3 lysine (Lys, K) residues in the C2A (Lys
191
, Lys
192
, Lys
196
) and C2B (Lys
326
, Lys
327
, 
Lys
331
) domains were replaced with glutamine (Gln, Q), and these mutants were designated C2A 
3KQ and C2B 3KQ, respectively (Fig. 3A). Such mutations neutralize the positive charge of each 
Lys residue without greatly affecting the overall size of the side chain. Cells with wild-type (WT) 
and mutant synaptotagmin I were cotransfected with syntaxin 1 into HEK293 cells, and the 
effects of the charge-neutralizing mutations on their binding were examined. Immunoblotting 
analysis showed no significant differences in the expression levels of the proteins in the 3 types 
of transfected cells, indicating that the WT and mutant synaptotagmins were expressed and stably 
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existed in the transfected cells and that they had no significant effects on syntaxin expression 
levels (Fig. 3B). 
When synaptotagmin was immunoprecipitated from the cell lysate, the C2A 3KQ mutant 
coprecipitated syntaxin at levels similar to those of the WT synaptotagmin, indicating that 
mutation of the Lys residues in the C2A domain did not impair the ability of synaptotagmin to 
bind syntaxin in the absence of Ca
2+
 (Fig. 3C and D). In contrast, mutation of the Lys residues in 
the C2B domain inhibited coprecipitation with syntaxin by 80% (Fig. 3C and D). Although the 
Ca
2+
-binding sites of synaptotagmin were intact, Ca
2+
 addition to the cell lysates did not alter the 
syntaxin binding in all 3 types of synaptotagmin (Fig. 3C and D), which was similar to the results 
with the brain extract demonstrated in Fig. 1B. These results indicated that the Lys residues in the 
4 strand of the synaptotagmin I C2B domain were critical for its Ca
2+
-independent binding to 
syntaxin 1. 
 
Synaptotagmin-binding sites on syntaxin 
 
As described above, the positively charged Lys residues in the C2B domain constitute the 
syntaxin 1-binding sites on synaptotagmin I, suggesting that the synaptotagmin I-binding sites on 
syntaxin 1 could be formed by negatively charged acidic residues. Previous studies have shown 
that many syntaxin-binding proteins interact with the third C-terminal of the syntaxin H3 domain 
that is absolutely required for neurotransmitter release (Wu et al., 1999). The H3 domain contains 
14 negatively charged amino acid residues [glutamate (Glu, E) and aspartate (Asp, D)] that are 
highly conserved across species (Fig. 4A). We thus attempted to determine the 
synaptotagmin-binding sites by focusing on these residues. 
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In order to neutralize the negative charges of these amino acid residues, Glu and Asp were 
replaced with Gln and asparagine (Asn, N), respectively, in combination with an adjacent residue, 
and a series of mutations was generated (designated as E194/196Q, E201/206Q, E211Q/D214N, 
D218N, E224/228Q, D231N/E234Q, E238Q/D242N, and D250N). All mutant syntaxins were 
expressed at levels similar to those of WT syntaxin in HEK293 cells cotransfected with 
synaptotagmin (Fig. 4B). The cell lysate containing synaptotagmin and the WT or mutant 
syntaxin was immunoprecipitated with an anti-synaptotagmin antibody and subjected to 
immunoblotting. Three double-mutant syntaxins with mutations in the N-terminal half of the H3 
domain (E194/196Q, E201/206Q, and E211Q/D214N) decreased the Ca
2+
-independent 
syntaxin-synaptotagmin binding by ~50% compared to WT syntaxin (Figs. 4C and D). In contrast, 
syntaxins with mutations in the C-terminal half of the H3 domain (D218N, E224/228Q, 
D231N/E234Q, E238Q/D242N, and D250N) were coprecipitated with synaptotagmin at similar 
or slightly higher levels than WT syntaxin, but these differences were not statistically significant. 
In order to further probe the role of the acidic residues in the N-terminal half of the syntaxin H3 
domain, mutations were simultaneously introduced into 5 Glu residues (E194/196/201/206/211Q). 
The quintuple-mutant syntaxin (5EQ) was expressed in transfected cells at levels similar to those 
of WT syntaxin (Fig. 4E), and synaptotagmin binding was inhibited to 35% compared to the WT 
(Figs. 4D and E). These results indicate that the N-terminal half of the syntaxin H3 domain 
contains redundant synaptotagmin-binding sites that are formed by multiple negatively charged 
amino acid residues. 
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Discussion 
 
In Ca
2+
-dependent neurotransmitter release, synaptotagmin I may play a role as a Ca
2+
 sensor 
in order to synchronize SNARE-mediated synaptic vesicle exocytosis. Therefore, elucidating the 
exact properties of the synaptotagmin-SNARE complex binding is a critical problem. Here, we 
examined the interaction between solubilized native synaptotagmin and SNAREs from the rat 
brain. We found that synaptotagmin bound to SNARE complexes at physiological ionic strengths 
in the absence of Ca
2+
. Moreover, using recombinant proteins that were overexpressed in cultured 
mammalian cells, we demonstrated that synaptotagmin directly bound to syntaxin, but not to 
SNAP-25 or synaptobrevin 2, in a Ca
2+
-independent manner. Multiple negatively charged amino 
acid residues in the syntaxin H3 domain were at least partially involved in the binding to the 
synaptotagmin C2B domain. These results indicate the possibility that synaptotagmin I may act 
on the SNARE complex through the binding to syntaxin 1 in presynaptic nerve terminals at 
resting Ca
2+
 levels. 
Although many studies have shown an interaction between synaptotagmin and syntaxin, its 
physiological significance has been uncertain. Our results reveal for the first time that the 
Ca
2+
-independent binding of synaptotagmin to syntaxin 1 required the adjacent Lys residues 
localized on the 4 strand of the synaptotagmin I C2B domain, and these residues are important 
for the actions of synaptotagmin during neurotransmitter release. Our findings are consistent with 
the previous findings of a NMR analysis that demonstrated that the C2B 4 strand participates in 
Ca
2+
-independent synaptotagmin-SNARE complex binding (Dai et al., 2007). Moreover, 
mutations in those Lys residues abolish synaptotagmin-t-SNARE heterodimer binding (Rickman 
et al., 2004). Thus, these findings suggest that synaptotagmin I apparently binds to SNARE 
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complexes through syntaxin 1. Microinjection of a synthetic peptide that is homologous to the 4 
strand completely blocks neurotransmitter release (Bommert et al., 1993). In rescue experiments, 
synaptotagmin I with mutations in its Lys residues in the C2B4 strand lost the ability to rescue 
transmitter release from synaptotagmin-deficient neurons (Borden et al., 2005; Li et al., 2006; 
Mackler and Reist, 2001). In Drosophila, these residues were required for Ca
2+
-independent 
docking/priming of synaptic vesicles at the neuromuscular junction (Loewen et al., 2006). Given 
these findings, we conclude that synaptotagmin I-syntaxin 1 binding at resting Ca
2+
 levels is 
essential for synaptotagmin I’s function in neurotransmitter release.  
Syntaxin 1 was originally identified as a synaptotagmin I-binding protein from rat brain 
extracts in the absence of Ca
2+
 (Bennett et al., 1992; Yoshida et al., 1992). A subsequent study 
showed that synaptotagmin can be coimmunoprecipitated with syntaxin and the other 
components of SNARE complexes from bovine brain extracts in the presence of a chelating agent 
(Söllner et al., 1993). Thus, our results confirmed these previous findings and showed that tagless 
full-length recombinant synaptotagmin and syntaxin expressed in mammalian cells possessed 
their intrinsic binding properties. Many studies have examined the synaptotagmin-SNARE 
interaction, and most of them have demonstrated that the binding was highly Ca
2+
 dependent (Bai 
et al., 2004b; Dai et al., 2007; Fernández-Chacón et al., 2001; Hui et al., 2009; Wang et al., 2003; 
Zhang et al., 2002). One of the reasons for the Ca
2+
-dependent binding observed in previous 
studies could be the use of soluble cytoplasmic fragments that were fused with various tags that 
were designed so that the protein could be rapidly and simply purified by affinity 
chromatography. Further studies will be needed in order to clarify these discrepancies. 
A previous study reported that synaptotagmin I did not bind to syntaxin 1 alone, even when 
binding experiments were performed using proteins purified from brain (Rickman et al., 2004). 
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Whereas the synaptotagmin-syntaxin complex was observed in the cotransfected cell lysates (Fig. 
2), we did not observe their binding when the proteins were expressed individually in HEK293 
cells and then mixed together after solubilizing (data not shown). These findings suggest that at 
least 1 of either of the proteins might need to be integrated into the cell membrane in order to 
bind Ca
2+
 independently. The conformation of syntaxin in solution can be different from that in 
the plasma membrane because botulinum type C neurotoxin can cleave syntaxin 1 only if the 
protein is incorporated into a lipid bilayer (Schiavo et al., 1995). 
Although synaptotagmin-syntaxin binding was not increased by Ca
2+
 under our experimental 
conditions, many studies have reported Ca
2+
-dependent enhancement of the binding. The 
Ca
2+
-dependent binding to syntaxin requires the synaptotagmin C2A domain (Kee and Scheller, 
1996; Li et al., 1995), and mutating the Asp residues in the C2A Ca
2+
-binding sites completely 
abolishes the binding (Davis et al., 1999; Shao et al., 1997). However, synaptotagmin with the 
same mutation still possesses the ability to trigger neurotransmitter release (Robinson et al., 
2002). Therefore, we suggest that the physiological significance of the Ca
2+
-enhanced 
synaptotagmin I-syntaxin 1 interaction might be for reasons other than Ca
2+
-dependent synaptic 
vesicle exocytosis.  
We did not detect direct synaptotagmin I-SNAP-25 binding in the absence of Ca
2+
, which is 
in agreement with a previous study (Rickman and Davletov, 2003). However, some studies have 
reported a Ca
2+
-independent interaction between them (Gerona et al., 2000; Schiavo et al., 1997). 
A possible interpretation for this discrepancy is that their lower binding affinity is due to the fact 
that chemical cross-linking is needed in order to efficiently detect the synaptotagmin-SNAP-25 
complex (Zhang et al., 2002). Similarly, NMR analysis indicated the possibility of their lower 
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binding specificity (Dai et al., 2007). Further studies are required to clarify these differences in 
synaptotagmin-SNAP-25 binding.  
Figure 5 illustrates our model of the role of Ca
2+
-independent synaptotagmin-SNARE 
complex binding in neurotransmitter release. After vesicle docking to the presynaptic membrane, 
SNARE assembly may be initiated at the N-terminal end and then proceed toward the C-terminal 
transmembrane regions in a process called zippering (Melia et al., 2002; Sørensen et al., 2006). In 
this model, we propose that synaptotagmin I binds the partially zipped SNARE complexes 
through syntaxin. Synaptotagmin I has 2 roles in neurotransmitter release: triggering synchronous 
release and suppressing asynchronous release (Nishiki and Augustine, 2004b; Shin et al., 2003; 
Yoshihara and Littleton, 2002). We previously showed that Ca
2+
 binding to the C2B domain is 
essential for synchronizing transmitter release but not for suppressing asynchronous release 
(Nishiki and Augustine, 2004a). Synaptotagmin I inhibits SNARE-mediated liposome fusion in 
the absence of Ca
2+
 (Chicka et al., 2008). More recently, the poly-Lys motif has also been shown 
to be critical for synaptotagmin II, which is closely related to synaptotagmin I, in suppressing 
asynchronous release (Kochubey and Schneggenburger, 2011). Given these findings, we 
postulate that synaptotagmin
 
I suppresses SNARE-mediated membrane fusion by binding to 
syntaxin 1 before
 
Ca
2+
 influx. 
When an action potential arrives, Ca
2+
 influxes into the presynaptic nerve terminals, binds to 
synaptotagmin, and triggers neurotransmitter release. Although we observed no effects of Ca
2+
 on 
synaptotagmin-SNARE binding under our experimental conditions, interestingly, Ca
2+
 has been 
shown to elicit the dissociation of synaptotagmin from the SNARE complexes in intact plasma 
membranes (Leveque et al., 2000). If this is the case, Ca
2+
 may release SNARE complexes from 
clamping by synaptotagmin in the presence of phospholipids and allow the complex to 
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completely assemble. Moreover, the Ca
2+
-dependent penetration of synaptotagmin into lipid 
bilayers may trigger SNARE-mediated membrane fusion (Bai et al., 2004a; Herrick et al., 2006; 
Hui et al., 2009; Martens et al., 2007). A key question, which remains to be addressed, is how 
Ca
2+
-bound synaptotagmin triggers membrane fusion. 
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Experimental methods 
 
Antibodies 
 
Monoclonal antibodies against synaptotagmin I (1D12), syntaxin 1 (9A7), and SNAP-25 
(BR05) and polyclonal antibodies against synaptobrevin 2 were prepared as described previously 
(Leveque et al., 1992; Nishiki et al., 1994; Oho et al., 1995; Shimazaki et al., 1996; Takahashi et 
al., 1991; Yoshida et al., 1992). A monoclonal antibody against botulinum type B neurotoxin 
(B-102; Kozaki et al., 1998) was used as a control IgG. 
 
Solubilization of rat brain synaptosomes 
 
Synaptosomes were prepared from rat brains by a modification of the procedures of 
Whittaker (Nishiki et al., 1994; Whittaker, 1959). The animal maintenance and experimental 
procedures were approved by the Okayama University Animal Experimentation Committee. 
Crude synaptosomal fractions were suspended in 20 mM Hepes-NaOH buffer (pH 7.4) 
containing 0.15 M NaCl (HBS) and then mixed with an equal volume of the same buffer 
containing 1% (w/v) Triton X-100 and Complete protease inhibitor cocktail (EDTA-free, Roche 
Diagnostics Corporation, Indianapolis, IN, USA). After 30 min on ice, the insoluble materials 
were removed by centrifugation at 100,000 × g for 1 h. The supernatant is hereafter referred to as 
the brain extract. Protein concentrations were determined to be 2 mg/mL by the bicinchoninic 
acid method using bovine serum albumin as a reference protein (Smith et al., 1985). 
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Expression constructs and site-directed mutagenesis 
 
A plasmid encoding full-length synaptotagmin I was described previously (Nishiki and 
Augustine, 2004a). Plasmids encoding syntaxin 1A, SNAP-25B, and synaptobrevin 2 were kind 
gifts from Dr. M. Takahashi (Kitasato University School of Medicine, Sagamihara, Japan). 
cDNAs were amplified by PCR using the following primers: syntaxin 1, 
5′-ATGAAGGACCGAACCCAGGA-3′ (sense) and 5′-CTATCCAAAGATGCCCCCGAT-3′ 
(antisense); SNAP-25, 5′-ATGGCCGAGGACGCAGACAT-3′ (sense) and 
5′-TTAACCACTTCCCAGCATCTTTGTT-3′ (antisense); and synaptobrevin 2, 
5′-ATGTCGGCTACCGCTGCCA-3′ (sense) and 5′-TTAAGTGCTGAAGTAAACGATGATGATG-3′ 
(antisense). The amplified products were ligated into a pCR-Script vector (Agilent Technologies, 
Inc., Santa Clara, CA, USA) and then subcloned into pIRES2-DsRed2 (Clonthech Laboratories, 
Inc., Mountain View, CA, USA) with EcoR I and Sac II restriction enzyme sites. Mutagenesis 
was performed using the QuikChange Site-Directed Mutagenesis kit (Agilent Technologies, Inc.) 
and the following mutagenic primers: C2A 3KQ, 
5′-CAGCAATTTGAGACTCAAGTCCACCGGAAAACC-3′ (sense); C2B 3KQ, 
5′-GCAACAGAGGACGATTCAGAAGAACACACTCAA-3′ (sense); E194/196Q, 
5′-GCCCTCAGTCAGATCCAGACCAGGCACAG-3′ (sense); E201/206Q, 
5′-GTCAGATCATCAAGTTGCAGAACAGCATCCGGG-3′ (sense); E211Q/D214N, 
5′-CACGATATGTTCATGAACATGGCCATGCTGGTGG-3′ (sense); D218N, 
5′-CACGATATGTTCATGAACATGGCCATGCTGGTGG-3′ (sense); E224/228Q; 
5′-GCAGAGCCAGGGGCAGATGATTGACAG-3′ (sense); D231N/E234Q, 
5′-GGAGATGATTAACAGGATCCAGTACAATGTGGAACACG-3′ (sense); E238Q/D242N, 
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5′-GTGCAACACGCTGTGAACTACGTGGAGAGGG-3′ (sense); and D250N, 
5′-GAGGGCCGTGTCTAACACCAAGAAGGCC-3′ (sense). All antisense primers were 
designed to be complementary to corresponding sense primers. The nucleotide sequences of all 
constructs were verified by DNA sequencing. 
 
Expression of recombinant proteins in HEK293 cells 
 
HEK293FT cells were grown in Dulbecco’s Modified Eagle’s Medium (DMEM) 
supplemented with 10% (v/v) FBS (Gibco, Invitrogen Corporation, Carlsbad, CA, USA), 
penicillin-streptomycin (100 units/mL and 100 g/mL, respectively), and 0.5 g/mL geneticin in 
a humidified 5% CO2 atmosphere at 37°C. Only cells from passages ≤25 were used. 
HEK293 cells were plated on a 10-cm plastic culture dish and transfected the next day using 
Lipofectamine 2000 (Invitrogen Corporation) according to the manufacturer’s instructions. In 
brief, DNA plasmids (4 μg) and Lipofectamine 2000 reagents (7.2 μL) were diluted separately 
with 400 μL of DMEM, mixed, and then added to each dish containing the cells. After incubation 
at 37°C for 4–5 h in a CO2 incubator, the medium was replaced with a fresh growth medium. 
Three days after transfection, cells were rinsed twice with 4 mL of HBS and solubilized with 1 
mL of HBS containing 0.5% (w/v) Triton X-100 and protease inhibitors (lysis buffer) at 4°C for 
20 min with gentle shaking. The insoluble materials were removed by centrifugation at 104,000 × 
g for 1 h, and the supernatant was referred to as the cell lysate. 
 
Immunoprecipitation 
 
 20 
All procedures were performed at 4°C. The brain extracts (1 mg in 500 μL) or cell lysates (400 
μL) were incubated with an antibody (50 μL) for 1 h in the presence of 1 mM CaCl2 or 2 mM 
EGTA, which was followed by a further 1-h incubation with Protein G Sepharose beads (10 μL, 
GE Healthcare, Piscataway, NJ, USA). The beads were washed twice by low speed centrifugation 
with 750 μL of lysis buffer, and precipitated proteins were analyzed by SDS-PAGE and 
immunoblotting (Nishiki et al., 1994). Immunoreactive bands were visualized by enhanced 
chemiluminescence using ECL plus (GE Healthcare) and Bio-Rad Versadoc (Model 5000, 
Bio-Rad Laboratories, Inc., Hercules, CA, USA) and quantified using a computer software 
(Quantity One, Bio-Rad Laboratories, Inc.). All measurements were performed within the linear 
range of the assay, as determined from a standard curve. In Figures 2–4, the amount of 
coprecipitated syntaxin was corrected by the corresponding synaptotagmin signal and then 
normalized to the data for 0.15 M NaCl (Fig. 2), WT synaptotagmin (Fig. 3), or WT syntaxin 
(Fig. 4). 
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Figure captions 
 
Fig. 1. Ca
2+
-independent synaptotagmin-soluble N-ethylmaleimide-sensitive factor attachment 
protein receptor (SNARE) complex binding in the brain extract. (A) Proteins were 
immunoprecipitated (IP) from the brain extracts (1 mg of protein) containing 2 mM ethylene 
glycol tetraacetic acid (EGTA) using an anti-synaptotagmin (Syt1), anti-synaptobrevin 2 (Syb2), 
or control (Cont.) antibody in the presence of 0.15 or 1.0 M NaCl (see Experimental methods). 
Twenty percent of the precipitates and the brain extract (1 µg) were analyzed by immunoblotting 
for Syt1, syntaxin 1 (Stx1), 25-kDa synaptosomal-associated protein (SNAP25), and Syb2. (B) 
Effects of Ca
2+
 on synaptotagmin-SNARE complex binding. The brain extracts containing 0.15 
M NaCl were immunoprecipitated in the presence of 2 mM EGTA (−) or 1 mM Ca2+ (+) and 
analyzed as described in A. The differences in the signal intensity of the immunoreactivity 
between A and B were due to different exposure times. The data shown are representative of 3 
independent experiments. 
 
Fig. 2. Recombinant synaptotagmin-SNARE binding in the absence of Ca
2+
. (A) Coexpression of 
synaptotagmin (Syt1) with syntaxin (Stx1), SNAP25, or synaptobrevin 2 (Syb2) in HEK293 cells. 
(B) Immunoprecipitation of synaptotagmin from the cell lysate coexpressing one of the SNAREs 
in the presence of 0.15 M NaCl and 2 mM EGTA using an anti-synaptotagmin antibody (Syt) or 
control IgG (Cont.). Precipitates were analyzed by immunoblotting as described in Fig. 1A. 
Nonspecific immunoreactive bands are indicated by an asterisk (*). (C) Coimmunoprecipitation 
of synaptotagmin and syntaxin in the presence of 0.15 or 1 M NaCl. Results that are 
representative of the 3 independent experiments are shown on the left. The immunoreactive 
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bands of coprecipitated syntaxin were measured, corrected by the corresponding synaptotagmin 
signal, and normalized to the value obtained with 0.15 M NaCl. The averaged data is shown in 
the bar graph on the right. Values are mean ± SEM from 3 experiments. ***p = 0.0002, by t-test. 
 
Fig. 3. Effects of mutations in the poly-Lysine (Lys) regions in the C2 domains on 
Ca
2+
-independent synaptotagmin-syntaxin binding. (A) Structures of the C2A (left, Sutton et al., 
1995) and the C2B (right, Fernandez et al., 2001) domains in the presence of Ca
2+
 (spheres) that 
were generated using the ICM software (MolSoft L.L.C., San Diego, CA, USA). The locations of 
the Lys residues that were mutated in this study are shown in black with their corresponding 
residue numbers. (B) Overexpression of synaptotagmin and syntaxin in HEK293 cells. Syntaxin 
(Stx1) was cotransfected with either wild-type (WT) or mutant synaptotagmin (C2A 3KQ or C2B 
3KQ) in HEK293 cells. (C) The immunoprecipitation of synaptotagmin with syntaxin from the 
cell lysate in the presence of EGTA or Ca
2+
. Precipitates were analyzed by immunoblotting. The 
data shown are representative of 3 independent experiments. (D) Syntaxin signals were corrected 
by the corresponding synaptotagmin signal and averaged. Values are mean ± SEM from 3 
experiments. ***p < 0.001, by one-way ANOVA with Tukey’s test.  
 
Fig. 4. Effects of mutations in the H3 domain of syntaxin on Ca
2+
-independent binding to 
synaptotagmin. (A) Alignment of the H3 domain sequences of syntaxin 1 from multiple 
organisms. The conserved negatively charged residues (E and D) are highlighted. (B) 
Overexpression of synaptotagmin (Syt1) and WT or mutant syntaxin (Stx1) that were 
cotransfected in HEK293 cells. (C) Coimmunoprecipitation of synaptotagmin with the WT or 
mutant syntaxin (E194/196Q–D250N). The cell lysate was immunoprecipitated with an 
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anti-synaptotagmin antibody and analyzed by immunoblotting for synaptotagmin (Syt1) and 
syntaxin (Stx1). (D) The immunoreactive bands of coprecipitated syntaxin were measured, 
corrected by the corresponding synaptotagmin signal, and normalized to the WT syntaxin. Values 
are mean ± SEM from 3–4 experiments. *p < 0.05; **p < 0.01, ***p < 0.001, by one-way 
ANOVA with Dunnett’s test compared to the WT syntaxin. (E) Coimmunoprecipitation of 
synaptotagmin with WT or quintuple mutant (5EQ) syntaxin. 
 
Fig. 5. A model of synaptotagmin-syntaxin binding in neurotransmitter release. Symbols 
represent synaptotagmin I (syt), syntaxin 1 (stx), SNAP-25 (sn25), and synaptobrevin 2 (syb); SV 
indicates a synaptic vesicle, and PM indicates the presynaptic plasma membrane; Ca
2+
 ions are 
shown as small, dark gray spheres. 
